Cost-Utility Analysis of the Cochlear Implant in Children
Open Access
- 16 August 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 284 (7), 850-856
- https://doi.org/10.1001/jama.284.7.850
Abstract
Impairment of hair cell function induces profound deafness in approximately 0.3% of children younger than 5 years.1,2 Cochlear implants may affect the auditory rehabilitation of an estimated 200,000 US children with profound deafness who fail to benefit from conventional hearing aids. Rising health care costs, due in part to advances such as the cochlear implant, have led to pressures that discourage the use of cost-increasing technology. Two thirds of US health care plans cited "no timely cost-effectiveness data" as a barrier to reimbursement.3 Policymakers, third-party payers, and pediatricians have called for more cost-effectiveness data on pediatric cochlear implantation.Keywords
This publication has 12 references indexed in Scilit:
- A Cost‐Utility Analysis of Pediatric Cochlear ImplantationThe Laryngoscope, 2000
- THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATESInternational Journal of Technology Assessment in Health Care, 2000
- A Prospective Study of the Cost-Utility of the Multichannel Cochlear ImplantJAMA Otolaryngology–Head & Neck Surgery, 1999
- Cost-Utility of the Cochlear Implant in AdultsA Meta-analysisJAMA Otolaryngology–Head & Neck Surgery, 1999
- Trends in Educational Placement and Cost-Benefit Considerations in Children With Cochlear ImplantsJAMA Otolaryngology–Head & Neck Surgery, 1999
- The effectiveness of cost-effectiveness analysis in containing costsJournal of General Internal Medicine, 1998
- Cost Utility of the Multichannel Cochlear Implant in 258 Profoundly Deaf IndividualsThe Laryngoscope, 1996
- Measuring health status in the community: a comparison of methods.Journal of Epidemiology and Community Health, 1994
- A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer.Journal of Clinical Oncology, 1992
- Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapyJournal of the American College of Cardiology, 1992